Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...
Alaya.bio, a biotechnology company developing a scalable polymeric delivery platform to precisely target and reprogram cells in situ, is pleased to announce an expanded collaboration with Michel ...
NEW YORK--(BUSINESS WIRE)--Alaya.bio, a biotechnology company developing a scalable polymeric delivery platform to precisely target and reprogram cells in situ, is pleased to announce an expanded ...
Dec. 12, 2024 — The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the ... Dec. 12, 2024 — The future of ...
When 3D printing was first introduced in 1985, it marked a major turning point for the manufacturing industry. In addition to ...